| |
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients PHASE 3 Study
|
| |
| |
This study is not yet open for participant recruitment.
Verified by Novartis, March 2011
First Received: March 17, 2011
http://clinicaltrials.gov/ct2/show/NCT01318694?term=alisporivir&rank=1
|
|
| |
| |
|
|
|
